SecBot SecBot
PRESS-RELEASE ·Filed Nov 16, 2026

MPLT

MapLight Therapeutics, Inc.
BULLISH
Impact 5/10
Processed18h 14m ago Wirepress-3403378
Press release · Earnings

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3403378

Track record

36 reports on MPLT

Performance horizon

5 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +57.24% at T+60 after the May 18, 2026 report. 6 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Bearish 5/10 Entry $6.97 Now $6.90 +0.93% settles Dec 15
  2. Nov 16, 2026today 8-K Neutral 3/10 Entry $7.34 Now $6.90 −5.99% settles Dec 15
  3. Nov 16, 2026today S-3 Neutral 4/10 Entry $7.37 Now $6.90 −6.38% settles Dec 15
  4. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $7.37 Now $6.90 −6.38% settles Dec 15
  5. Nov 16, 2026today Press Release Bullish 5/10 Viewing Entry $7.37 Now $6.90 −6.38% settles Dec 15
  6. Oct 16, 20264w ago Insider Cluster Bearish 4/10 Entry $8.00 to $6.90 Now $6.90 +13.75% ▲ +13.75% +10.29% vs SPY
  7. Oct 15, 20264w ago 144 Neutral 2/10 Entry $7.70 to $7.25 Now $6.90 −10.39% ▼ −5.84% −4.68% vs SPY
  8. Oct 15, 20264w ago 144 Neutral 2/10 Entry $7.70 to $7.25 Now $6.90 −10.39% ▼ −5.84% −4.68% vs SPY
  9. Oct 15, 20264w ago 144 Neutral 2/10 Entry $7.70 to $7.25 Now $6.90 −10.39% ▼ −5.84% −4.68% vs SPY
  10. Sep 24, 20267w ago EFFECT Neutral 4/10 Entry $10.76 to $8.25 Now $6.90 −35.87% ▼ −23.33% −22.91% vs SPY
Showing 10 of 36

US Market Status

Market Closed · Opens in 7h 59m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 16, 2026

Fresh MPLT Intelligence

Analysis is for subscribers only.

Subscribe for Full Access